PEStore

Buyout PE

Mosaic Capital Partners

Mosaic Capital Partners acquires controlling stakes in established, profitable businesses, from Charlotte, NC. It states a focus on healthcare & life sciences, business & professional services, industrials & manufacturing and construction.

Disclosed holdings21
Earliest stated investment2014
HeadquartersCharlotte, NC
Largest single fundNot stated

Stated investment criteria

What Mosaic Capital Partners says it buys

Read from Mosaic Capital Partners’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Revenue it states$10m to $100m1
EBITDA it states$5m to $15m1
Transaction typesPlatform1
Founded20132
People listed on its team page102

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Mosaic Capital Partners states that it takes majority or outright ownership. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Mosaic Capital Partners to consider any particular business, and nothing on this page is represented as being for sale.

Regulatory record

How Mosaic Capital Partners is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised2 · $133m gross
SEC adviser numberCRD 334830

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Mosaic Capital Partners lists on its own website. 16 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
EMT201412
ETAK201511
LGS201511
Pete's201511
Advanced Diagnostic Group201610
PLI Card Marketing Solutions201610
Galfab20179
Best Friends Pet Care20188
Sayers20188
Boston Retail Solutions20197
Custom Profile20197
NuSource20215
Zero Waste Recycling20215
Gautier Steel20233
Ickler Electric20251
Southern Shade Tree20260
LINXX Global
PLI Cards
Zero Waste LLC
bostonrs.com
treestoday.com

Compiled from Mosaic Capital Partners’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Mosaic Capital Partners?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.